Start-Up Quarterly Statistics, Q4 2012

05 Feb 2013

• By Deanna Kamienski

Start-ups raised a total of $670.3 million across all industries in Q4 2012, just $11.6 million less than in Q3, and 90% of that money went to biopharma companies. Several start-up companies inked deals with Big Pharmas, and there were three acquisitions – two in biopharma and one in the device sector.

In the fourth quarter of 2012, start-up companies raised a total of $670.3 million across all industries, which was just $11.6 million less than in Q3. (See Exhibit 1.) Biopharmas brought in 90% of the money ($602.4 million) and medical device companies raised only $48.2 million during Q4, nearly four times less than in the previous quarter. In vitro diagnostic start-ups’ fundraising also lagged, with only $19.7 million raised.

Exhibit 1